quinacrine has been researched along with Bradykinesia in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quinacrine attenuated SAM-induced hypokinesia without affecting SAM metabolism prior to its action on rat brain." | 1.33 | Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats. ( Charlton, CG; Lee, ES; Soliman, KF, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, ES | 1 |
| Soliman, KF | 1 |
| Charlton, CG | 1 |
1 other study available for quinacrine and Bradykinesia
| Article | Year |
|---|---|
Lysophosphatidylcholine decreases locomotor activities and dopamine turnover rate in rats.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Dopamine | 2005 |